- Home
- PPBT vs ATPC Comparison
PPBT vs ATPC Comparison
Compare PPBT & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- ATPC
- Stock Information
- Founded
- PPBT 2010
- ATPC 2016
- Country
- PPBT Israel
- ATPC Malaysia
- Employees
- PPBT N/A
- ATPC N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- ATPC Medical/Nursing Services
- Sector
- PPBT Health Care
- ATPC Health Care
- Exchange
- PPBT Nasdaq
- ATPC Nasdaq
- Market Cap
- PPBT 6.3M
- ATPC 83.5M
- IPO Year
- PPBT N/A
- ATPC N/A
- Fundamental
- Price
- PPBT $2.40
- ATPC $1.38
- Analyst Decision
- PPBT Strong Buy
- ATPC
- Analyst Count
- PPBT 1
- ATPC 0
- Target Price
- PPBT $33.00
- ATPC N/A
- AVG Volume (30 Days)
- PPBT 23.8K
- ATPC 56.7K
- Earning Date
- PPBT 08-15-2025
- ATPC 08-13-2025
- Dividend Yield
- PPBT N/A
- ATPC N/A
- EPS Growth
- PPBT N/A
- ATPC N/A
- EPS
- PPBT N/A
- ATPC N/A
- Revenue
- PPBT N/A
- ATPC $1,293,141.00
- Revenue This Year
- PPBT N/A
- ATPC N/A
- Revenue Next Year
- PPBT N/A
- ATPC N/A
- P/E Ratio
- PPBT N/A
- ATPC N/A
- Revenue Growth
- PPBT N/A
- ATPC N/A
- 52 Week Low
- PPBT $2.00
- ATPC $0.90
- 52 Week High
- PPBT $13.95
- ATPC $6.80
- Technical
- Relative Strength Index (RSI)
- PPBT 47.68
- ATPC 42.81
- Support Level
- PPBT $2.26
- ATPC $1.26
- Resistance Level
- PPBT $2.45
- ATPC $1.38
- Average True Range (ATR)
- PPBT 0.14
- ATPC 0.11
- MACD
- PPBT -0.01
- ATPC -0.00
- Stochastic Oscillator
- PPBT 44.12
- ATPC 29.55
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.